Fifth Third Bancorp’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $839 | Buy |
+111
| New | +$839 | ﹤0.01% | 2447 |
|
|
2023
Q4 | – | Sell |
-358
| Closed | -$4K | – | 2537 |
|
|
2023
Q3 | $4K | Buy |
358
+339
| +1,784% | +$3.79K | ﹤0.01% | 2231 |
|
|
2023
Q2 | $407 | Sell |
19
-25
| -57% | -$536 | ﹤0.01% | 2565 |
|
|
2023
Q1 | $1.78K | Hold |
44
| – | – | ﹤0.01% | 2567 |
|
|
2022
Q4 | $2.05K | Hold |
44
| – | – | ﹤0.01% | 2427 |
|
|
2022
Q3 | $2K | Hold |
44
| – | – | ﹤0.01% | 2420 |
|
|
2022
Q2 | $2K | Sell |
44
-18
| -29% | -$818 | ﹤0.01% | 2428 |
|
|
2022
Q1 | $4K | Sell |
62
-2
| -3% | -$129 | ﹤0.01% | 2359 |
|
|
2021
Q4 | $5K | Buy |
64
+45
| +237% | +$3.52K | ﹤0.01% | 2321 |
|
|
2021
Q3 | $1K | Buy |
+19
| New | +$1K | ﹤0.01% | 2560 |
|
|
2019
Q4 | – | Sell |
-28
| Closed | -$2K | – | 2237 |
|
|
2019
Q3 | $2K | Buy |
+28
| New | +$2K | ﹤0.01% | 2047 |
|
|
2016
Q1 | – | Sell |
-37
| Closed | -$1K | – | 2408 |
|
|
2015
Q4 | $1K | Sell |
37
-21
| -36% | -$568 | ﹤0.01% | 2594 |
|
|
2015
Q3 | $2K | Buy |
+58
| New | +$2K | ﹤0.01% | 2592 |
|